Immune responses to pertussis vaccines and disease (Q26824237)

Journal of Infectious Diseases

published in

1 reference

volume

209 Suppl 1

1 reference

page(s)

S10-5

1 reference

Reenforcing or booster injection of pertussis vaccine in previously immunized children of kindergarten age.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Th2-polarisation of cellular immune memory to neonatal pertussis vaccination.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Pertussis antibodies in postpartum women and their newborns

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Efficacy of an acellular pertussis vaccine among adolescents and adults.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Bordatella pertussis respiratory infection in children Is associated with preferential activation of Type 1 T helper cells

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Kinetics of pertussis immune responses to tetanus-diphtheria-acellular pertussis vaccine in health care personnel: implications for outbreak control

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Natural history of pertussis antibody in the infant and effect on vaccine response

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

AN ATTEMPT TO INCREASE RESISTANCE TO PERTUSSIS IN NEWBORN INFANTS BY IMMUNIZING THEIR MOTHERS DURING PREGNANCY.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Pertussis circulation has increased T-cell immunity during childhood more than a second acellular booster vaccination in Dutch children 9 years of age.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

A Safety and Immunogenicity Comparison of 12 Acellular Pertussis Vaccines and One Whole-Cell Pertussis Vaccine Given as a Fourth Dose in 15- to 20-Month-Old Children

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021

Immunogenicity of a three-component acellular pertussis vaccine administered at birth

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT560

7 January 2021